Skip to main content
US pharma giant Gilead Sciences seeks marketing authorisation from India for remdesivir - The Indian Express 31-May-2020
US pharma giant Gilead Sciences seeks marketing authorisation from India for remdesivir - The Indian Express
Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said. The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Adminis…
More...